On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...
The French drugmaker’s newly launched respiratory syncytial virus antibody Beyfortus far exceeded analyst expectations, ...
Sanofi and partner AstraZeneca recently increased production capacity for their RSV antibody shot, sales of which jumped ...
GlobalData on MSN4d
Sanofi’s $17bn sale of Opella to US investors advances following government dealA stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...
Zacks.com on MSN4d
Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake SaleSanofi SNY has entered into exclusive negotiations with U.S.-based private equity company Clayton Dubilier & Rice (CD&R) for ...
Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice ...
When Sanofi announced last week that it plans to sell a 50% controlling stake of Opella, its consumer helath business, the ...
India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...
Building on the expertise and radioligand pipeline of Orano Med, Sanofi and Orano will invest in a new entity, operating under the Orano Med brand ... high value-added products and services ...
Morehouse School of Medicine may play a role in changing the lack of diversity in clinical testing as one of three historically Black medical schools receiving a $18 million gift from Sanofi, the ...
US plane maker Boeing is heading into a busy week, with investors watching developments closely around its costly labour ...
Sanofi and Orano join forces to develop next-generation radioligand medicinesParis, October 17, 2024. Sanofi and Orano Med, a subsidiary of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback